Latest News About Rsv Vaccine Eligibility

Updated 2026-04-26 19:02

I don’t have live tool access in this turn, but I can share the latest widely reported guidance on RSV vaccine eligibility up to now.

Suggested next steps to confirm eligibility in your area:

If you’d like, I can tailor this to your country (France) and provide the latest local eligibility details from public health sources.

Sources

Get your no-cost RSV vaccine today - CVS

The CDC recommends eligible adults receive a single dose of the RSV vaccine. Learn more about respiratory syncytial virus or schedule your appointment at CVS.

www.cvs.com

ACIP Votes to Expand Recommendation for Pfizer's RSV Vaccine ...

Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74 Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of respiratory syncytial virus (RSV) vaccines approved for adults 50-59 years of age at increased risk of RSV-associated lower respiratory tract disease (LRTD). This includes...

www.pfizer.com

CDC Revises RSV Vaccine Guidelines Over Side Effect Concerns

The CDC has published updated recommendations for older adults, detailing who should get vaccinated against RSV. The move comes after concerns were raised earlier this year that the shot may be linked to a heightened risk of a rare nervous system condition called Guillain-Barré syndrome.

www.webmd.com

U.S. FDA Approves Pfizer's RSV Vaccine ABRYSVO® for Adults ...

First and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 Approval based on data from pivotal Phase 3 trial in adults at increased risk of lower respiratory tract disease caused by RSV Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO ® (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of lower respiratory tract disease (LRTD) caused...

www.pfizer.com

CDC, HHS recommend RSV, seasonal flu vaccines | AHA News

The Centers for Disease Control and Prevention and the Department of Health and Human Services adopted Aug. 4 the Advisory Committee on Immunization Practices’ recommendations for respiratory syncytial virus and seasonal influenza vaccinations ahead of the 2025-2026 respiratory infection season.

www.aha.org